Episode 21 - Vaccinations in Rheumatology

Recorded December 8, 2013 9:45 PM

Main Topic

  1. 2013 IDSA Clinical Practice Guidelines for Vaccination of the Immunocompromised Host

  2. Vaccinology and DMARD Use in Immunocompromised and High-Risk Populations

  3. PDF Expert 5 for iPad

Pneumonia Vaccine Recommendations in Rheumatology Patients

  • For patients who have not previously received either PCV13 or PPSV23, a single dose of PCV13 should be given, followed by a dose of PPSV23 at least eight weeks later.
  • For patients who have previously received one or more doses of PPSV23, a single dose of PCV13 should be given one or more years after the last PPSV23 dose was received.
  • For patients who require additional doses of PPSV23, the first such dose should be given no sooner than eight weeks after PCV13 and at least five years after the most recent dose of PPSV23.

Source: Uptodate